Business Standard

Jagsonpal Pharmaceuticals Ltd Announcements

BY EXCHANGE :

ANNOUNCEMENTSUBJECTATTACHMENTBROADCAST DATE
Announcement under Regulation 30 (LODR)-Updates on Acquisition We now wish to inform you that on completion of customary conditions the transac...Read More31/05/2024
Announcement under Regulation 30 (LODR)-Press Release / Media Release Please find enclosed herewith copy of press release isuued by the company titled...Read More24/05/2024
Announcement under Regulation 30 (LODR)-Newspaper Publication Please find enclosed copies of advertisement published on May 22 2024 in Busines...Read More22/05/2024
Compliances-Reg.24(A)-Annual Secretarial Compliance Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requi...Read More21/05/2024
Disclosure Of Related Party Transaction Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Please find enclosed related party disclosure for the half year ended October 01...Read More20/05/2024
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS Intimation of grant of Employee Stock Options20/05/2024
Corporate Action-Board to consider Dividend The Board of Directors at their meeting held today have recommended dividend of ...Read More20/05/2024
Announcement under Regulation 30 (LODR)-Press Release / Media Release Please find enclosed press release and Investor Deck for the quarter and year en...Read More20/05/2024
Outcome Of Board Meeting Held On May 20 2024 Along With Audited (Standalone) Financial Results For The Quarter And Year Ended March 31 2024 Please find enclosed Audited Financial Result for the year ended March 31 2024 a...Read More20/05/2024
Board Meeting Outcome for Outcome Of Board Meeting Held On May 20 2024 Along With Audited (Standalone) Financial Results For The Quarter And Year Ended March 31 2024 Pursuant to Regulation 30 (read with Part A of Schedule III) and Regulation 33 o...Read More20/05/2024
Announcement under Regulation 30 (LODR)-Acquisition We wish to inform you that Jagsonpal Pharmaceuticals Limited (the Company) has s...Read More16/05/2024
Board Meeting Intimation for Considering The Audited Financial Result Of The Company For The Quarter And Year Ended March 31 2024 And Recommendation Of Dividend If Any For The Financial Year Ended March 31 2024. JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of ...Read More13/05/2024
Announcement under Regulation 30 (LODR)-Press Release / Media Release In term of Regulation 30 of the SEBI (LODR) Regulations 2015 please find enclose...Read More10/05/2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation for issuance of Letter of Confirmation under SEBI LODR Regulations 20...Read More07/05/2024
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS Pursuant to SEBI (Listing Obligation and Disclosure Requirements) Regulations 20...Read More04/05/2024
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 <b>Format of the Annual Disclosure to be made by an entity identified as a Large...Read More29/04/2024
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A <b>Format of Initial Disclosure to be made by an entity identified as a Large Co...Read More29/04/2024
Submission Of Certificate From Practising Company Secretary Under Reg. 40(9) Of SEBI (LODR) Reg. 2015 We hereby submit a certificate from Practising Company Secretary under Reg. 40(9...Read More25/04/2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Req...Read More12/04/2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 In Compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regu...Read More02/04/2024

Load more